RecruitingNCT06546488

Cognitive Assessment Tools for Huntington's Disease.

Cognitive Assessment Tools for Individuals With Huntington's Disease.


Sponsor

Ohio State University

Enrollment

76 participants

Start Date

Jun 20, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the current proposal is to expand understanding of two currently available cognitive tools that are not typically used in Huntington Disease (HD) clinical trials that might be useful both for initial screening and for clinical trial application. One is the Coding Test and the other is the Self-Administered Gerocognitive Examination (SAGE). Both the Coding Test and the SAGE have been used for assessments of individuals with other neurodegenerative diseases, including Alzheimer's Disease, Parkinson's Disease and Lewy Body Disease, but data is lacking on their use in individuals with HD.


Eligibility

Min Age: 30 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Assessments for people with huntington disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAssessments

A standardized assessment battery will be administered. It will consist of cognitive, functional and motor assessments.


Locations(1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06546488


Related Trials